{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:10:54Z","timestamp":1775315454185,"version":"3.50.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["89934"],"award-info":[{"award-number":["89934"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.cjca.2018.12.015","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T21:07:00Z","timestamp":1544821620000},"page":"310-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Mechanisms of Arrhythmia and Sudden Cardiac Death in Patients With HIV Infection"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2602-7987","authenticated-orcid":false,"given":"Judith","family":"Brouillette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Cyr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Fiset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2018.12.015_bib1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection","volume":"348","author":"Bozzette","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.12.015_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.12.015_bib3","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(98)03201-2","article-title":"Changing patterns of mortality across Europe in patients infected with HIV-1","volume":"352","author":"Mocroft","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2018.12.015_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIR.0b013e3181d2c863","article-title":"Assessing risk for cardiovascular disease in patients with human immunodeficiency virus: why it matters","volume":"121","author":"Sax","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.12.015_bib5","first-page":"1657","article-title":"QTc interval prolongation in patients with HIV and AIDS","volume":"97","author":"Sani","year":"2005","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.cjca.2018.12.015_bib6","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/QAD.0b013e32832d3b85","article-title":"Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study","volume":"23","author":"Grunfeld","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.cjca.2018.12.015_bib7","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of Death in HIV-1\u2013infected patients treated with antiretroviral therapy, 1996\u20132006: collaborative analysis of 13 HIV cohort studies","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2018.12.015_bib8","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.jacc.2012.02.024","article-title":"Sudden cardiac death in patients with human immunodeficiency virus infection","volume":"59","author":"Tseng","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/0002-9149(91)90251-F","article-title":"Sudden unexpected death in persons <40 years of age","volume":"68","author":"Drory","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib10","author":"Raju"},{"key":"10.1016\/j.cjca.2018.12.015_bib11","author":"Peterson"},{"key":"10.1016\/j.cjca.2018.12.015_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijcard.2018.05.100","article-title":"Role of genetic heart disease in sentinel sudden cardiac arrest survivors across the age spectrum","volume":"270","author":"Giudicessi","year":"2018","journal-title":"Int J Cardiol"},{"issue":"suppl A","key":"10.1016\/j.cjca.2018.12.015_bib13","first-page":"37A","article-title":"Epidemiology and mechanisms of sudden cardiac death","volume":"21","author":"Zipes","year":"2005","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib14","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1161\/01.CIR.98.21.2334","article-title":"Sudden cardiac death","volume":"98","author":"Zipes","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.12.015_bib15","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1089\/aid.2013.0061","article-title":"Prevalence and factors associated with a prolonged QTc interval in a cohort of asymptomatic HIV-infected patients","volume":"29","author":"Moreno","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.cjca.2018.12.015_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2459\/JCM.0000000000000436","article-title":"Prevalence and predictors of long corrected Qt interval in HIV-positive patients: a multicenter study","volume":"18","author":"Gili","year":"2017","journal-title":"J\u00a0Cardiovasc Med"},{"key":"10.1016\/j.cjca.2018.12.015_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1310\/hct1004-261","article-title":"Prevalence and risk factors of prolonged QTc interval in HIV-infected patients: results of the HIV-HEART study","volume":"10","author":"Reinsch","year":"2009","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.cjca.2018.12.015_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000320216","article-title":"Viral load and CD4+ cell count as risk factors for prolonged QT interval in HIV-infected subjects: a cohort-nested case-control study in an outpatient population","volume":"117","author":"QaQa","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.cjca.2018.12.015_bib19","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1111\/j.1540-8159.1997.tb05439.x","article-title":"Long QTc and torsades de pointes in human immunodeficiency virus disease","volume":"20","author":"Kocheril","year":"1997","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5830\/CVJA-2016-007","article-title":"Electrocardiographic findings in a cross-sectional study of human immunodeficiency virus (HIV) patients in Enugu, south-east Nigeria","volume":"27","author":"Njoku","year":"2016","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.cjca.2018.12.015_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/157488610789869265","article-title":"QT alterations in psychopharmacology: proven candidates and suspects","volume":"5","author":"Alvarez","year":"2010","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.cjca.2018.12.015_bib22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1124\/pr.110.003723","article-title":"Drug-induced long QT syndrome","volume":"62","author":"Kannankeril","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.cjca.2018.12.015_bib23","unstructured":"Montaner J, Guillemi S, Harris M. Therapeutic guidelines for antiretroviral (ARV) treatment of adult HIV infection. 2015. Committee for Drug Evaluation and Therapy of the BC Centre for Excellence in HIV\/AIDS."},{"key":"10.1016\/j.cjca.2018.12.015_bib24","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.cjca.2017.09.001","article-title":"A\u00a0practical approach to avoiding cardiovascular adverse effects of psychoactive medications","volume":"33","author":"Brouillette","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2261-12-124","article-title":"QTc interval prolongation in HIV-infected patients: a case\u2013control study by 24-hour Holter ECG recording","volume":"12","author":"Fiorentini","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cjca.2018.12.015_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1345\/aph.1K681","article-title":"Etravirine has no effect on QT and corrected QT interval in HIV-negative volunteers","volume":"42","author":"Peeters","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cjca.2018.12.015_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0091270008329551","article-title":"Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT study","volume":"49","author":"Damle","year":"2009","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.cjca.2018.12.015_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.clpt.6100263","article-title":"Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies","volume":"83","author":"Sarapa","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cjca.2018.12.015_bib29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/0091270008318007","article-title":"Raltegravir thorough QT\/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval","volume":"48","author":"Iwamoto","year":"2008","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.cjca.2018.12.015_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/j.1875-9114.2012.01033.x","article-title":"Effect of a single supratherapeutic dose of dolutegravir on cardiac repolarization","volume":"32","author":"Chen","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2018.12.015_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2125.2008.03138.x","article-title":"Effect of single doses of maraviroc on the QT\/QTc interval in healthy subjects","volume":"65","author":"Davis","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cjca.2018.12.015_bib32","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1345\/aph.1A454","article-title":"Efavirenz-associated QT prolongation and torsade de pointes arrhythmia","volume":"36","author":"Castillo","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cjca.2018.12.015_bib33","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/jce.13032","article-title":"Efavirenz inhibits the human ether-a-go-go related current (hERG) and induces QT interval prolongation in CYP2B6*6*6 allele carriers","volume":"27","author":"Abdelhady","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"9460","key":"10.1016\/j.cjca.2018.12.015_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0140-6736(05)70936-3","article-title":"Blockade of HERG channels by HIV protease inhibitors","volume":"365","author":"Anson","year":"2005","journal-title":"LANCET"},{"issue":"3","key":"10.1016\/j.cjca.2018.12.015_bib38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/QAD.0b013e328341dcc0","article-title":"Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations","volume":"25","author":"Soliman","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.cjca.2018.12.015_bib39","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/cid\/cit467","article-title":"Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy","volume":"57","author":"Vallecillo","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2018.12.015_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10840-015-0077-2","article-title":"Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?","volume":"45","author":"Romero","year":"2016","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203890","article-title":"Prevalence and trends of polypharmacy among HIV-positive and negative men in the Multicenter AIDS Cohort Study from 2004 to 2016","volume":"13","author":"Ware","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cjca.2018.12.015_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40360-016-0053-1","article-title":"Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect: comprehensive overview of clinical trials","volume":"17","author":"Wisniowska","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"issue":"9","key":"10.1016\/j.cjca.2018.12.015_bib43","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/clc.20945","article-title":"Acquired long QT interval: a case series of multifactorial QT prolongation","volume":"34","author":"Digby","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12245-008-0052-0","article-title":"Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus","volume":"1","author":"Prosser","year":"2008","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.cjca.2018.12.015_bib45","first-page":"69","article-title":"Drug dosing in renal disease","volume":"32","author":"Doogue","year":"2011","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.cjca.2018.12.015_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00003088-197601020-00002","article-title":"Renal failure, drug pharmacokinetics and drug action","volume":"1","author":"Fabre","year":"1976","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cjca.2018.12.015_bib47","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2165\/00003088-198005060-00002","article-title":"Hepatic disease and drug pharmacokinetics","volume":"5","author":"Williams","year":"1980","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.cjca.2018.12.015_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00002018-199717010-00004","article-title":"Drug administration in chronic liver disease","volume":"17","author":"Westphal","year":"1997","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.cjca.2018.12.015_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1008656930082","article-title":"Effect of hepatic insufficiency on pharmacokinetics and drug dosing","volume":"20","author":"Verbeeck","year":"1998","journal-title":"Pharm World Sci PWS"},{"key":"10.1016\/j.cjca.2018.12.015_bib50","first-page":"30","article-title":"Risk factors for gastrointestinal adverse events in HIV treated and untreated patients","volume":"11","author":"Hill","year":"2009","journal-title":"AIDS Rev"},{"key":"10.1016\/j.cjca.2018.12.015_bib51","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.mcg.0000225694.46874.fc","article-title":"Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy","volume":"41","author":"Siddiqui","year":"2007","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cjca.2018.12.015_bib52","first-page":"13","article-title":"Opportunistic infections update","year":"1998","journal-title":"Proj Inf Perspect"},{"key":"10.1016\/j.cjca.2018.12.015_bib53","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/379833a0","article-title":"The inward rectification mechanism of the HERG cardiac potassium channel","volume":"379","author":"Smith","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2018.12.015_bib54","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A\u00a0mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.cjca.2018.12.015_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.yjmcc.2007.05.007","article-title":"Cardiac repolarization is prolonged in CD4C\/HIV transgenic mice","volume":"43","author":"Brouillette","year":"2007","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib56","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.yjmcc.2009.02.025","article-title":"Ventricular K+ currents are reduced in mice with elevated levels of serum TNFa","volume":"47","author":"Grandy","year":"2009","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/415219a","article-title":"New ideas about atrial fibrillation 50 years on","volume":"415","author":"Nattel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2018.12.015_bib58","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.jacc.2013.03.022","article-title":"Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity","volume":"61","author":"Hsu","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194754","article-title":"Atrial arrhythmia prevalence and characteristics for human immunodeficiency virus-infected persons and matched uninfected controls","volume":"13","author":"Sanders","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cjca.2018.12.015_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026320","article-title":"Association of low level viremia with inflammation and mortality in HIV-infected adults","volume":"6","author":"Eastburn","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cjca.2018.12.015_bib61","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cjca.2018.12.015_bib62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2007.09.006","article-title":"Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study","volume":"155","author":"Marcus","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2018.12.015_bib63","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.12.015_bib64","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1540-8167.2009.01713.x","article-title":"Reduction of ventricular sodium current in a mouse model of HIV","volume":"21","author":"Grandy","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib65","doi-asserted-by":"crossref","first-page":"21896","DOI":"10.1074\/jbc.M114.549642","article-title":"Interleukin-1\u03b2 reduces L-type Ca2+ current through protein kinase C\u03f5 activation in mouse heart","volume":"289","author":"El Khoury","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cjca.2018.12.015_bib66","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.cjca.2018.08.007","article-title":"Age as a critical determinant of atrial fibrillation: a two-sided relationship","volume":"34","author":"Laredo","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib67","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/QAI.0000000000001470","article-title":"CHA2DS2-VASc score, warfarin use, and risk for thromboembolic events among HIV-infected persons with atrial fibrillation","volume":"76","author":"Chau","year":"2017","journal-title":"J\u00a0Acquir Immune Defic Syndr 1999"},{"key":"10.1016\/j.cjca.2018.12.015_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2003.02.002","article-title":"Heart rate variability in human immunodeficiency virus-positive individuals","volume":"94","author":"Mittal","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10286-017-0461-3","article-title":"Acute onset autonomic dysfunction and orthostatic syncope as an early manifestation of HIV infection","volume":"28","author":"Kohno","year":"2018","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cjca.2018.12.015_bib70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1540-8159.2006.00297.x","article-title":"Power spectral analysis of heart rate variability in HIV-infected and AIDS patients","volume":"29","author":"Correia","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib71","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s13365-013-0160-3","article-title":"Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy","volume":"19","author":"Robinson-Papp","year":"2013","journal-title":"J\u00a0Neurovirol"},{"key":"10.1016\/j.cjca.2018.12.015_bib72","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0002-8703(98)70014-6","article-title":"Abnormalities of the QT interval in primary disorders of autonomic failure","volume":"136","author":"Choy","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2018.12.015_bib73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1310\/hct1203-141","article-title":"Cardiovagal autonomic function in HIV-infected patients with unsuppressed HIV viremia","volume":"12","author":"Chow","year":"2011","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.cjca.2018.12.015_bib74","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/COH.0000000000000408","article-title":"Current assessment of heart rate variability and Qtc interval length in HIV\/AIDS","volume":"12","author":"Mcintosh","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.cjca.2018.12.015_bib75","doi-asserted-by":"crossref","first-page":"R814","DOI":"10.1152\/ajpregu.00529.2013","article-title":"HIV-1-Tat excites cardiac parasympathetic neurons of nucleus ambiguus and triggers prolonged bradycardia in conscious rats","volume":"306","author":"Brailoiu","year":"2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib76","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-018-1500-0","article-title":"The role of HIV Tat protein in HIV-related cardiovascular diseases","volume":"16","author":"Jiang","year":"2018","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.cjca.2018.12.015_bib77","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7150\/ijms.4441","article-title":"Effects of antiretroviral therapy on autonomic function in early HIV infection: a preliminary report","volume":"9","author":"Chow","year":"2012","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.cjca.2018.12.015_bib78","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199906033402203","article-title":"Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1: a report from the Sydney Blood Bank Cohort","volume":"340","author":"Learmont","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.12.015_bib79","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0092-8674(91)90097-I","article-title":"Importance of the nef gene for maintenance of high virus load and for development of AIDS","volume":"65","author":"Kestler","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.cjca.2018.12.015_bib80","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1128\/JVI.72.1.121-132.1998","article-title":"Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease","volume":"72","author":"Hanna","year":"1998","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cjca.2018.12.015_bib81","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(00)81748-1","article-title":"Nef harbors a major determinant of pathogenicity for AIDS-like disease by HIV-1 in transgenic mice","volume":"95","author":"Hanna","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.cjca.2018.12.015_bib82","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1152\/physrev.00002.2005","article-title":"Molecular physiology of cardiac repolarization","volume":"85","author":"Nerbonne","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cjca.2018.12.015_bib83","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.yjmcc.2011.07.017","article-title":"HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs","volume":"51","author":"Bai","year":"2011","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2016.08.022","article-title":"HIV-Tat induces a decrease in I Kr and I Ks via reduction in phosphatidylinositol-(4,5)-bisphosphate availability","volume":"99","author":"Es-Salah-Lamoureux","year":"2016","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib85","doi-asserted-by":"crossref","first-page":"H1672","DOI":"10.1152\/ajpheart.00955.2001","article-title":"Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage","volume":"282","author":"Raidel","year":"2002","journal-title":"AJP Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib86","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2018.12.015_bib87","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugalcdep.2018.06.026","article-title":"Substance use patterns among women living with HIV compared with the general female population of Canada","volume":"191","author":"Shokoohi","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.cjca.2018.12.015_bib88","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1089\/apc.2008.0022","article-title":"Coping strategies and patterns of alcohol and drug use among HIV-infected patients in the United States Southeast","volume":"22","author":"Pence","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.cjca.2018.12.015_bib89","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1521\/aeap.2009.21.3_supp.106","article-title":"Cigarette smoking and HIV: more evidence for action","volume":"21","author":"Reynolds","year":"2009","journal-title":"AIDS Educ Prev"},{"key":"10.1016\/j.cjca.2018.12.015_bib90","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/14622200801908190","article-title":"Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy","volume":"10","author":"Shuter","year":"2008","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.cjca.2018.12.015_bib91","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s10461-008-9449-2","article-title":"Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation","volume":"14","author":"Tesoriero","year":"2010","journal-title":"AIDS Behav"},{"key":"10.1016\/j.cjca.2018.12.015_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158535","article-title":"Alcohol drinking pattern: a comparison between HIV-infected patients and individuals from the general population","volume":"11","author":"Ikeda","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cjca.2018.12.015_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107451","article-title":"Tobacco smoking in HIV-infected versus general population in France: heterogeneity across the various groups of people living with HIV","volume":"9","author":"Tron","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cjca.2018.12.015_bib94","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M14-0954","article-title":"Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys","volume":"162","author":"Mdodo","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2018.12.015_bib95","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11904-015-0285-5","article-title":"The impact of alcohol use and related disorders on the HIV continuum of care: a systematic review: alcohol and the HIV continuum of care","volume":"12","author":"Vagenas","year":"2015","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.cjca.2018.12.015_bib96","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2018.12.015_bib97","first-page":"791","article-title":"Alcohol effects on cardiac function","volume":"Vol 5","author":"Gardner","year":"2015"},{"key":"10.1016\/j.cjca.2018.12.015_bib98","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/clc.20746","article-title":"Cocaine and the heart","volume":"33","author":"Maraj","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib99","doi-asserted-by":"crossref","first-page":"PL143","DOI":"10.1016\/S0024-3205(99)00370-7","article-title":"Nicotine depresses the functions of multiple cardiac potassium channels","volume":"65","author":"Wang","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.cjca.2018.12.015_bib100","first-page":"H1081","article-title":"Inactivation gating determines nicotine blockade of human HERG channels","volume":"277","author":"Wang","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib101","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3565(24)29321-6","article-title":"Effects of cocaine and its major metabolites on the HERG-encoded potassium channel","volume":"299","author":"Ferreira","year":"2001","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.cjca.2018.12.015_bib102","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1124\/mol.59.2.269","article-title":"Inhibition of human ether-a-go-go potassium channels by cocaine","volume":"59","author":"O\u2019Leary","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.cjca.2018.12.015_bib103","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1124\/mol.59.5.1069","article-title":"Cocaine blocks HERG, but not KvLQT1+minK, potassium channels","volume":"59","author":"Zhang","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.cjca.2018.12.015_bib104","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12012-010-9074-y","article-title":"Comparison of the effects of methadone and heroin on human ether-a-go-go-related gene channels","volume":"10","author":"Zunkler","year":"2010","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.cjca.2018.12.015_bib105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12012-009-9035-5","article-title":"Dilated cardiomyopathy in transgenic mice expressing HIV Tat","volume":"9","author":"Fang","year":"2009","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.cjca.2018.12.015_bib106","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jelectrocard.2005.09.001","article-title":"Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients","volume":"39","author":"Nordin","year":"2006","journal-title":"J\u00a0Electrocardiol"},{"key":"10.1016\/j.cjca.2018.12.015_bib107","unstructured":"Quinn T. Global epidemiology of HIV infection. April 2018. UpToDate.com."},{"key":"10.1016\/j.cjca.2018.12.015_bib108","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.amjmed.2012.06.037","article-title":"Electrolyte disorders in community subjects: prevalence and risk factors","volume":"126","author":"Liamis","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2018.12.015_bib109","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5527\/wjn.v5.i1.33","article-title":"Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients","volume":"5","author":"Musso","year":"2016","journal-title":"World J Nephrol"},{"key":"10.1016\/j.cjca.2018.12.015_bib110","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2008.02.003","article-title":"High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection","volume":"201","author":"Guimaraes","year":"2008","journal-title":"Atherosclerosis"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1831376X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1831376X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T14:16:50Z","timestamp":1775312210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X1831376X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0828282X1831376X"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2018.12.015","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of Arrhythmia and Sudden Cardiac Death in Patients With HIV Infection","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2018.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}